Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 trial shows safety and efficacy of intravenous palonosetron to prevent postoperative nausea and vomiting in pediatric patients; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron (palonosetron)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2014-08-15